Insider · CIK 0001715429
J. Anthony Ware
Files at ANAB (ANAPTYSBIO, INC), TRAX (First Tracks Biotherapeutics, Inc.). First filing Sep 4, 2026, latest Sep 4, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TRAX: First Tracks Biotherapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | TRAXsell First Tracks Biotherapeutics, Inc. | $1.8M 39,265 shares | -71% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | TRAX First Tracks Biotherapeutics, Inc. | MOption exercise Common Stock | +39,265 | $5.74 | $225k | 54,925 | 38 d ago |
| Sep 2, 2026 | TRAX First Tracks Biotherapeutics, Inc. | SOpen-market sale Common Stock | -39,265 | $44.78 | $1.8M | 15,660 | 38 d ago |
| Sep 2, 2026 | TRAX First Tracks Biotherapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative | -28,571 | $0.00 | $0 | 0 | 38 d ago |
| Sep 2, 2026 | TRAX First Tracks Biotherapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative | -10,694 | $0.00 | $0 | 0 | 38 d ago |
| Jun 15, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +6,030 | $0.00 | $0 | 13,530 | Jun 17, 2025 |
| Jun 15, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -6,030 | $0.00 | $0 | 0 | Jun 17, 2025 |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | AGrant or award Stock Option (right to buy)derivative | +16,510 | $0.00 | $0 | 16,510 | Jan 7, 2025 |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | AGrant or award Restricted Stock Unitderivative | +6,030 | $0.00 | $0 | 6,030 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.